BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wittling MC, Cahalan SR, Levenson EA, Rabin RL. Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes. Front Immunol 2020;11:605673. [PMID: 33542718 DOI: 10.3389/fimmu.2020.605673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bencze D, Fekete T, Pázmándi K. Correlation between Type I Interferon Associated Factors and COVID-19 Severity. Int J Mol Sci 2022;23:10968. [PMID: 36142877 DOI: 10.3390/ijms231810968] [Reference Citation Analysis]
2 Córdova-Dávalos LE, Hernández-Mercado A, Barrón-García CB, Rojas-Martínez A, Jiménez M, Salinas E, Cervantes-García D. Impact of genetic polymorphisms related to innate immune response on respiratory syncytial virus infection in children. Virus Genes 2022. [PMID: 36085536 DOI: 10.1007/s11262-022-01932-6] [Reference Citation Analysis]
3 Sur D, Leonova K, Levi B, Markowitz SI, Cohen-harazi R, Gitlin I, Gurova K, Gudkov A, Pinhasov A, Koman I, Nesher E. Targeted Modulation of Interferon Response-Related Genes with IFN-Alpha/Lambda Inhibition. IJMS 2022;23:7248. [DOI: 10.3390/ijms23137248] [Reference Citation Analysis]
4 Szebeni J, Storm G, Ljubimova JY, Castells M, Phillips EJ, Turjeman K, Barenholz Y, Crommelin DJA, Dobrovolskaia MA. Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines. Nat Nanotechnol 2022. [PMID: 35393599 DOI: 10.1038/s41565-022-01071-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
5 Filipič B, Gradišnik L, Pereyra A, Mršić G, Andrašec M, Mazija H. The Enhancing Effects of 10% PBS Washout of Holocene Minerals on HuIFN-αN3 Inducing Capacity of NDV ZG1999HDS or Sendai virus (Cantell Strain). Life 2022;12:414. [DOI: 10.3390/life12030414] [Reference Citation Analysis]
6 Schuhenn J, Meister TL, Todt D, Bracht T, Schork K, Billaud JN, Elsner C, Heinen N, Karakoese Z, Haid S, Kumar S, Brunotte L, Eisenacher M, Di Y, Lew J, Falzarano D, Chen J, Yuan Z, Pietschmann T, Wiegmann B, Uebner H, Taube C, Le-Trilling VTK, Trilling M, Krawczyk A, Ludwig S, Sitek B, Steinmann E, Dittmer U, Lavender KJ, Sutter K, Pfaender S. Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection. Proc Natl Acad Sci U S A 2022;119:e2111600119. [PMID: 35131898 DOI: 10.1073/pnas.2111600119] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
7 Willemsen L, Chen H, van Roomen CPAA, Griffith GR, Siebeler R, Neele AE, Kroon J, Hoeksema MA, de Winther MPJ. Monocyte and Macrophage Lipid Accumulation Results in Down-Regulated Type-I Interferon Responses. Front Cardiovasc Med 2022;9:829877. [DOI: 10.3389/fcvm.2022.829877] [Reference Citation Analysis]
8 Li J, Kemper T, Broering R, Chen J, Yuan Z, Wang X, Lu M. Interferon Alpha Induces Cellular Autophagy and Modulates Hepatitis B Virus Replication. Front Cell Infect Microbiol 2022;12:804011. [DOI: 10.3389/fcimb.2022.804011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Brisse M, Huang Q, Rahman M, Di D, Liang Y, Ly H. RIG-I and MDA5 Protect Mice From Pichinde Virus Infection by Controlling Viral Replication and Regulating Immune Responses to the Infection. Front Immunol 2021;12:801811. [PMID: 34925387 DOI: 10.3389/fimmu.2021.801811] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Aricò E, Bracci L, Castiello L, Urbani F, Casanova JL, Belardelli F. Exploiting natural antiviral immunity for the control of pandemics: Lessons from Covid-19. Cytokine Growth Factor Rev 2021:S1359-6101(21)00092-7. [PMID: 34955389 DOI: 10.1016/j.cytogfr.2021.12.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wallace JW, Constant DA, Nice TJ. Interferon Lambda in the Pathogenesis of Inflammatory Bowel Diseases. Front Immunol 2021;12:767505. [PMID: 34712246 DOI: 10.3389/fimmu.2021.767505] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 Wei W, Ma D, Li L, Zhang L. Progress in the Application of Drugs for the Treatment of Multiple Sclerosis. Front Pharmacol 2021;12:724718. [PMID: 34326775 DOI: 10.3389/fphar.2021.724718] [Cited by in F6Publishing: 6] [Reference Citation Analysis]